Newsroom
Sorted by: Latest
-
Starr宣布完成对IQUW Group的收购
纽约 / 伦敦--(BUSINESS WIRE)--(美国商业资讯)-- Starr是一家全球投资与保险机构。公司今日宣布,已完成对IQUW Group的收购。本次交易将构建一个覆盖范围更广、结构更为多元的专业(再)保险业务平台,并显著提升其在伦敦市场、百慕大及英国零售汽车保险领域的服务能力。 整合后的Starr业务规模与服务能力进一步提升,在全球范围内覆盖更多专业险种及细分市场,为更广泛的客户与经纪人群体提供支持。通过并入IQUW Group,Starr在伦敦市场的竞争地位显著增强,其管理机构亦已跻身劳合社第九大管理机构之列。同时,Starr将继续以深厚的承保专业能力为核心,致力于为经纪人及客户提供一流的服务与体验。客户与经纪人将受益于更丰富的产品组合、更高效的决策机制、更为稳健的资本实力,以及持续拓展的全球业务布局。 此次交易亦显著增强了Starr的再保险业务能力。IQUW Re Bermuda及IQUW在伦敦的再保险业务现已统一以“Starr Re”品牌开展运营,专注承接集团的分入再保险业务,并进一步提升公司在不同地域与业务线之间提供多元化产品组合的能力。依托Starr雄厚的资本...
-
Starr順利完成收購IQUW集團的工作
紐約 & 倫敦--(BUSINESS WIRE)--(美國商業資訊)-- 全球投資及保險機構Starr今天宣布完成收購IQUW集團的工作。Starr的(再)保險平台藉由這次收購拓展服務層面並多元化專業實力,提升服務倫敦市場、百慕達及英國零售車險領域的能力。 合併之後,Starr現在可服務更多專業類別與細分市場的全球客戶與經紀商。納入IQUW集團讓Starr站穩倫敦市場,成為Lloyd旗下第九大管理代理機構。更重要的是,Starr接下來的營運策略將側重如何發揮承保專業能力以及優秀的經紀商與客戶體驗及服務。客戶與經紀商將受益於Starr更豐富的產品組合、高效的決策機制、更雄厚的資本實力以及更大的全球業務覆蓋範圍。 交易完成後,Starr的再保險能力也顯著提升。IQUW Re Bermuda與IQUW的倫敦的再保險業務現在將以「Starr Re」的名義運作,負責承保該公司的分入再保險業務,並進一步增強其在不同地域及業務線提供多元化產品組合的能力。Starr Re將受益於Starr雄厚的資本,得以在不同市場週期中審慎配置資本,讓該集團為整個(再)保險市場的廣大客戶提供更好的服務。 IQUW集團...
-
Agi Inc. Delivers Record Profit Exceeding R$1 Billion and Robust Assets Growth of 62% in 2025
SÃO PAULO--(BUSINESS WIRE)--Agi Inc. (NYSE: AGBK) (Agi), technology-powered provider of specialized financial services in Brazil, today released its financial results for the fourth quarter and full year ended December 31, 2025. The financial statements and earnings presentation are available on the Company’s Investor Relations website at investors.agiinc.com along with details of the earnings conference call to be held today at 5:00 p.m. Eastern Time (6:00 p.m. Brasilia time). “We delivered st...
-
Stockholder Notice: Robbins LLP Informs Investors of the Atara Biotherapeutics, Inc. Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Atara Biotherapeutics, Inc. (NASDAQ: ATRA) securities between May 20, 2024 and January 9, 2026. Atara develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the U.S. and the United Kingdom (“U.K.”). The Company’s lead product candidate is tabelecleucel (also referred to as tab-cel or EBVALLO), a T-ce...
-
Flowco Holdings Inc. Announces Closing of Public Offering by Selling Stockholders and Share Repurchase by the Company
HOUSTON--(BUSINESS WIRE)--Flowco Holdings Inc. (“Flowco”) (NYSE: FLOC) announced today the closing of an underwritten public offering (the “Offering”) by certain affiliates of GEC Advisors LLC (the “Selling Stockholders”) of an aggregate of 7,800,000 shares of Flowco’s Class A common stock at a public offering price of $22.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional aggregate 1,170,000 shares at the public offering pr...
-
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
DALLAS--(BUSINESS WIRE)--Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET...
-
Forum Energy Technologies to Present at the Investor Summit Virtual Conference
HOUSTON--(BUSINESS WIRE)--Forum Energy Technologies, Inc. (NYSE: FET) announced today that Neal Lux, President and Chief Executive Officer, and Lyle Williams, Executive Vice President and Chief Financial Officer, will present at the Investor Summit Virtual Conference on Wednesday, March 25, 2026 at 10:00 a.m. Central Time. The event is open access and interested parties can register through the following link: Investor Summit Virtual Conference Link A link to the live webcast and the presentati...
-
Element Solutions Inc Announces Board Leadership Transition
MIAMI--(BUSINESS WIRE)--Element Solutions Inc (NYSE:ESI) (“Element Solutions” or the “Company”), a global and diversified specialty chemicals technology company, today announced that Sir Martin E. Franklin, Executive Chairman of the Board, plans to step down from the Board and will not seek re-election at the upcoming 2026 Annual Meeting of Stockholders. Ian G.H. Ashken, a founding Board director since 2013 and Chair of the Board’s Nominating and Policies Committee, has been appointed Non-Execu...
-
The William Morrow Group Presents Six Exceptional Titles for Mother’s Day 2026 Book-Gifting Roundups
NEW YORK--(BUSINESS WIRE)--The William Morrow Group of HarperCollins Publishers announces a curated selection books perfect for Mother’s Day 2026 book-gifting roundups....
-
Emera Incorporated announces the closing of the offering of US$750 million Aggregate Principal Amount of Fixed-to-Fixed Reset Rate Junior Subordinated Notes
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Emera Incorporated (“Emera” or the “Company”) (TSX/NYSE: EMA) announced today that Emera US Finance, LLC (the “Issuer”) has completed the sale of US$750 million aggregate principal amount of United States dollar denominated junior subordinated notes, consisting of US$375 million aggregate principal amount of 6.650% Series A fixed-to-fixed reset rate junior subordinated notes due 2056 (the “Series A Notes”) and US$375 million aggregate principal amount of 6...